Consun Pharmaceutical Group Limited
CPHGF
$1.08
$0.0747.34%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 35.50M | 35.67M | 27.60M | 27.84M | 30.24M |
| Total Depreciation and Amortization | 1.68M | 1.69M | 2.75M | 2.78M | 2.73M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.33M | 3.35M | -6.17M | -6.22M | 7.36M |
| Change in Net Operating Assets | 10.70M | 10.75M | -- | -- | -1.20M |
| Cash from Operations | 51.20M | 51.45M | 24.19M | 24.40M | 39.13M |
| Capital Expenditure | -4.32M | -4.34M | -3.24M | -3.27M | -2.48M |
| Sale of Property, Plant, and Equipment | -10.40K | -10.40K | 32.90K | 33.20K | 500.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.43M | 2.44M | -7.82M | -7.88M | -18.81M |
| Cash from Investing | -1.90M | -1.91M | -11.02M | -11.12M | -21.29M |
| Total Debt Issued | 138.68M | 138.68M | 110.10M | 110.10M | 75.46M |
| Total Debt Repaid | -269.70M | -269.70M | -109.40M | -109.40M | -81.75M |
| Issuance of Common Stock | 9.46M | 9.46M | 62.04M | 62.04M | 2.53M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -16.01M | -16.09M | -31.08M | -31.35M | -8.18M |
| Other Financing Activities | 42.99M | 42.99M | -8.53M | -8.53M | -8.42M |
| Cash from Financing | -26.93M | -27.06M | -23.60M | -23.80M | -9.87M |
| Foreign Exchange rate Adjustments | -704.10K | -707.50K | -87.60K | -88.40K | -760.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 21.67M | 21.77M | -10.52M | -10.61M | 7.21M |